SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/934C12436E7A6D1496C0B3946D3DB756AA251C64D78003C9E882F0578F01F90BE8440007B810EA0BD239DB8612387F92>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/934C12436E7A6D1496C0B3946D3DB756AA251C64D78003C9E882F0578F01F90BE8440007B810EA0BD239DB8612387F92
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/934C12436E7A6D1496C0B3946D3DB756AA251C64D78003C9E882F0578F01F90BE8440007B810EA0BD239DB8612387F92
http://www.w3.org/2000/01/rdf-schema#comment
"to the best of our knowledge these results are the first clinical data indicating that nuclear VASH2 but not cytoplasmic VASH2 promotes cell proliferation by driving the cell cycle from the G0/G1 to S phase."
xsd:string
http://purl.uniprot.org/uniprot/#_985C420AFAB2560F6C2BCE0F58161956CCEB19F34D37D77B4A564CC7B9356A72BA33BA7FED58BD3225FDC0CCAF1158DC
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/934C12436E7A6D1496C0B3946D3DB756AA251C64D78003C9E882F0578F01F90BE8440007B810EA0BD239DB8612387F92
http://purl.uniprot.org/uniprot/Q86V25
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/934C12436E7A6D1496C0B3946D3DB756AA251C64D78003C9E882F0578F01F90BE8440007B810EA0BD239DB8612387F92
http://purl.uniprot.org/uniprot/#_Q86V25-mappedCitation-26177649
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/934C12436E7A6D1496C0B3946D3DB756AA251C64D78003C9E882F0578F01F90BE8440007B810EA0BD239DB8612387F92